5'-adenosine monophosphate-activated protein kinase subunit alpha (AMPK alpha) (AMPK alpha)

5'-adenosine monophosphate-activated protein kinase (AMPK) subunit alpha is the catalytic component of the heterotrimeric AMPK complex, which serves as a central energy sensor in eukaryotic cells (UniProt P54646). It is activated by an increase in the AMP:ATP ratio, signaling a state of low cellular energy, which leads to phosphorylation at the Thr172 residue by upstream kinases like LKB1 (PubMed: 14651840). Upon activation, AMPK alpha phosphorylates various downstream targets to switch off ATP-consuming anabolic pathways, such as fatty acid and cholesterol synthesis, while switching on ATP-producing catabolic pathways like glucose uptake and fatty acid oxidation (StatPearls: NBK538282). This makes it a critical regulator of metabolic homeostasis and a primary therapeutic target for metabolic disorders like type 2 diabetes and obesity (PubMed: 23235676). Beyond metabolism, AMPK alpha plays roles in regulating cell growth, autophagy, and mitochondrial health, often acting as a tumor suppressor in certain contexts (PubMed: 21464304). Pharmacological activation of AMPK alpha, either directly or indirectly through drugs like metformin, aims to improve insulin sensitivity and reduce systemic inflammation (PubMed: 28467931). However, therapeutic development faces challenges regarding tissue specificity and the potential for adverse effects like cardiac hypertrophy (PubMed: 29124330).

Other names

PRKAA1PRKAA2AMPK subunit alpha-1AMPK subunit alpha-2AMP-activated protein kinase catalytic subunit alpha

Activation of the AMPK complex to restore energy balance by promoting catabolic pathways (e.g., fatty acid oxidation, glucose uptake) and inhibiting anabolic pathways (e.g., lipid and protein synthesis).